Loading...

Tag trends are in beta. Feedback? Thoughts? Email me at [email protected]

New experimental malaria vaccine conferred a significant degree of protection from parasite infection and clinical malaria that was sustained over a span of 2 years without the need for a booster dose—a first for any malaria vaccine

The amount of infectious H5N1 influenza viruses in raw (unpasteurized) milk declined rapidly with heat treatment according to new laboratory research conducted by scientists at the National Institute of Allergy and Infectious Diseases

Researchers observed rapid immune system changes in small study of people who switched to vegan or ketogenic (keto) diet

Clinical Trial of HIV Vaccine Begins in United States and South Africa

First-in-Human Trial of Oral Drug to Remove Radioactive Contamination Begins

Universal Influenza Vaccine performs well in Phase 1 trail

Food Allergy Is Associated with Lower Risk of SARS-CoV-2 Infection

Peanut allergy affects about 2% of children in the United States

Peanut allergy affects about 2% of children in the United States

An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates

NIH scientists used bacteriophage viruses to successfully treat mice infected with multidrug-resistant Klebsiella pneumoniae, one of the biggest antibiotic resistance threats

An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study

NIH Scientists Identify Nutrient that Helps Prevent Bacterial Infection

NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced Covid-19

The virus that causes coronavirus disease 2019 (COVID-19) is stable for several hours to days in aerosols and on surfaces

Coronavirus infections: More than just the common cold. Two earlier novel CoV outbreaks initially caused global havoc.

Study Vaccine Protects Monkeys Against Four Types of Hemorrhagic Fever Viruses

Scientists newly identified set of three antibodies isolated from a person sick with the flu, and found the antibodies provided broad protection against several different strains of influenza when tested both in vitro and in mice, which could become the basis for new antivirals and vaccines.

Animals undergoing dietary restriction were better protected against tumors and bacterial infections than those with unrestricted diets

Novel antibody may suppress HIV for up to four months, suggests a new study

NIH researchers make progress toward Epstein-Barr virus (EBV) vaccine, with novel vaccine candidates that, in animals, elicited potent anti-EBV antibody responses that blocked infection of cell types involved in EBV-associated cancers

Gut microbes from healthy human infant donors transplanted into mice protected those exposed to milk from experiencing allergic reactions, finds a new study In Nature Medicine, which may lead to the development of microbiome-based therapies to prevent or treat food allergy.

A new NIH study unexpectedly found that a bacterium in probiotic supplements helps eliminate Staphylococcus aureus, a bacteria that can cause serious antibiotic-resistant infections

An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world

NIH Herpesvirus Study in Mice Leads to Discovery of Potential Broad-Spectrum Antiviral

New clinical trial results provide evidence that high-dose immunosuppressive therapy followed by transplantation of a person's own blood-forming stem cells can induce sustained remission of relapsing-remitting multiple sclerosis.

NIH Scientists Identify Antibody That Neutralizes Nearly All HIV Strains

NIH Scientists Discover Genetic Cause of Rare Allergy to Vibration

Active HIV Replication Discovered in Lymphoid Tissue of "Undetectable" HIV Patients

Study Finds Peanut Consumption in Infancy May Prevent Peanut Allergy

More →